Allogeneic bone marrow transplantation for chronic myelomonocytic leukemia in childhood: A report from the European Working Group on Myelodysplastic Syndrome in Childhood

Journal of Clinical Oncology

Volumn 15, Issue 2, 1997, Pages 566-573

  Locatelli, F ^a   Niemeyer, C ^a   Angelucci, E ^a   Bender Gotze C ^a   Burdach, S ^a   Ebell, W ^a   Friedrich, W ^a   Hasle, H ^a   Hermann, J ^a   Jacobsen, N ^a   Klingebiel, T ^a   Kremens, B ^a   Mann, G ^a   Pession, A ^a   Peters, C ^a   Schmid, H J ^a   Stary, J ^a   Suttorp, M ^a   Uderzo, C ^a   van't Veer Korthof, E T ^a   Vossen, J ^a   Zecca, M ^a   Zimmermann, M ^a   more..

^a UNIVERSITY OF PAVIA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

BUSULFAN; CYCLOPHOSPHAMIDE; CYCLOSPORIN A; CYTOTOXIC AGENT; ETOPOSIDE; MELPHALAN; THYMOCYTE ANTIBODY;

ALLOGENIC BONE MARROW TRANSPLANTATION; ARTICLE; CANCER SURVIVAL; CHILD; CHILDHOOD CANCER; CHRONIC MYELOMONOCYTIC LEUKEMIA; CLINICAL ARTICLE; FEMALE; GRAFT VERSUS HOST REACTION; HLA SYSTEM; HUMAN; INFANT; MALE; MYELODYSPLASTIC SYNDROME; PRIORITY JOURNAL; WHOLE BODY RADIATION;

EID: 18844465770     PISSN: 0732183X     EISSN: None     Source Type: Journal    
DOI: 10.1200/JCO.1997.15.2.566     Document Type: Article

References (35)

1. Freedman MH, Estrov Z, Chan HL: Juvenile chronic myelogeous leukemia. Am J Pediatr Hematol Oncol 10:261-267, 1988
2. Castro-Malaspina H, Schaison G, Passe S, et al.: Subacute and chronic myelomonocytic leukemia in children (juvenile CML). Cancer 54:675-686, 1984
3. Hann IM: Myelodysplastic syndrome. Arch Dis Child 67:962-966, 1992
4. Niemeyer C, Aricò M, Biondi A, et al.: Chronic myelomonocytic leukemia in childhood: A retrospective analysis of 104 patients. Blood 84:56, 1994 (suppl 1, abstr 214)
5. Chan HSL, Estrov Z, Weitzman SS, et al.: The value of intensive combination chemotherapy for juvenile chronic myelogenous leukemia. J Clin Oncol 5:1960-1967, 1987
6. Estrov Z, Dubé ID, Chan HSL, et al.: Residual juvenile chronic myelogenous leukemia cells detected in peripheral blood during clinical remission. Blood 70:1466-1469, 1987
7. Hazani A, Barak Y, Berant M, et al.: Congenital juvenile chronic myelogenous leukemia: Therapeutic trial with interferon alpha-2. Med Pediatr Oncol 21:73-76, 1993
8. Sanders JE, Buckner CD, Thomas ED, et al.: Allogeneic bone marrow transplantation for children with juvenile chronic myeloid leukaemia. Blood 71:1144-1146, 1988
9. Bunin NJ, Casper JT, Lawton C, et al.: Allogeneic marrow transplantation using T cell depletion for patients with juvenile chronic myelogenous leukemia without HLA-identical siblings. Bone Marrow Transplant 9:119-122, 1992
10. Donadieu J, Stephan JL, Blanche S, et al.: Treatment of juvenile chronic myelomonocytic leukemia by allogeneic bone marrow transplantation. Bone Marrow Transplant 13:777-782, 1994
11. Locatelli F, Pession A, Comoli P, et al.: Role of allogeneic bone marrow transplantation from HLA-identical sibling or matched unrelated donor in the treatment of children with juvenile chronic myeloid leukaemia. Br J Haematol 92:49-54, 1996
12. Suttorp M, Schmitz N, Prange E, et al.: Remission of juvenile chronic myeloid leukemia following graft failure of an unrelated marrow transplant and autologous recovery of marrow function promoted by GM-CSF and IL-3. Leukemia 5:723-725, 1991
13. Beatty PG, Clift RA, Mickelson EM, et al.: Marrow transplantation from related donors other than HLA-identical siblings. N Engl J Med 313:765-771, 1985
14. Storb R, Deeg HJ, Whitehead J, et al.: Methotrexate and cyclosporine compared with cyclosporine alone for prophylaxis of acute graft-versus-host disease after marrow transplantation for leukemia. N Engl J Med 314:729-735, 1986
15. Glucksberg H, Storb R, Fefer A, et al.: Clinical manifestations of graft-versus-host disease in human recipients of marrow from HLA-matched sibling donors. Transplantation 18:295-304, 1974
16. Shulman HM, Sullivan KM, Weiden PL, et al.: Chronic graft-versus-host syndrome in man. Am J Med 69:204-217, 1980
17. Goldman JM, McGlave P, Szydlo P, et al.: Impact of disease duration and prior treatment on outcome of bone marrow transplants for chronic myelogenous leukemia. Blood 80:170, 1992 (suppl 1, abstr 1598)
18. Ratanatharathorn V, Karanes C, Uberti J, et al.: Busulfan-based regimens and allogeneic bone marrow transplantation in patients with myelodysplastic syndromes. Blood 81:2194-2199, 1993
19. Locatelli F, Pession A, Bonetti F, et al.: Busulfan, cyclophosphamide and melphalan as conditioning regimen for bone marrow transplantation in children with myelodysplastic syndromes. Leukemia 8:844-849, 1994
20. Giorgiani G, Bozzola M, Locatelli F, et al.: Role of busulfan and total body irradiation on growth of pre-pubertal children receiving bone marrow transplantation and results of treatment with recombinant human growth hormone. Blood 86:825-831, 1995
21. Parth P, Kennedy RS, Lane NE, et al.: Motor and cognitive testing of bone marrow transplant patients after chemo-radiotherapy. Percept Mot Skills 68:1227-1241, 1989
22. Yaeger AM, Wagner JE, Graham ML: Optimization of busulfan dosage in children undergoing bone marrow transplantation: A pharmacokinetic study of dose escalation. Blood 79:2475-2480, 1992
23. Horowitz MM, Gale RP, Sondel PM, et al.: Graft-versus-leukemia reactions after bone marrow transplantation. Blood 75:555-562, 1990
24. Slavin S, Ackerstein A, Naparstek E, et al.: The graft-versus-leukemia (GVL) phenomenon: Is GVL separable from GVHD? Bone Marrow Transplant 6:155-161, 1990
25. Bacigalupo A, Van Lint MT, Occhini D, et al.: Increased risk of leukemia relapse with high-dose cyclosporine A after allogeneic marrow transplantation for acute leukemia. Blood 77:1423-1428, 1991
26. Barrett AJ, Horowitz MM, Gale RP, et al.: Marrow transplantation for acute lymphoblastic leukemia: Factors affecting relapse and survival. Blood 74:862-871, 1989
27. Buckner CD, Clift RA, Appelbaum FR, et al.: Effects of treatment regimens in patients allografted for acute and chronic myelogenous leukemia. Bone Marrow Transplant 7:6-8, 1991 (suppl 2)
28. Veys P, Saunders F, Calderwood S, et al.: The role of graft-versus-leukaemia in bone marrow transplantation for juvenile chronic myeloid leukaemia. Blood 84:337, 1994 (suppl 1, abstr 1334)
29. Passmore SJ, Hann IM, Stiller CA, et al.: Pediatric myelodysplasia: A study of 68 children and a new prognostic scoring system. Blood 85:1742-1750, 1995
30. Kalhs P, Schwarzinger I, Anderson G. et al.: A retrospective analysis of the long-term effect of splenectomy on late infections, graft-versus-host disease, relapse, and survival after allogeneic marrow transplantation for chronic myelogenous leukemia. Blood 86:2028-2032, 1995
31. Rassam SMB, Katz F, Chessells JM, et al.: Allogeneic transplantation using T cell depletion for patients with juvenile chronic myelogenous leukemia without HLA identical siblings. Bone Marrow Transplant 11:247-250, 1993
32. Smith OF, Sanders JE, Robertson KA, et al.: Allogeneic marrow transplantation (BMT) for children with juvenile chronic myelogenous leukemia (JCML). Blood 84:201, 1994 (suppl 1, abstr 790)
33. Anderson JE, Appelbaum FR, Fisher LD, et al.: Allogeneic bone marrow transplantation for 93 patients with myelodysplastic syndrome. Pretreatment variables and outcome. Blood 82:677-681, 1993
34. Kernan NA, Bartsch G, Ash RC, et al.: Analysis of 462 transplantations from unrelated donors facilitated by the National Marrow Donor Program. N Engl J Med 328:593-598, 1993
35. Casper J, Camitta B, Truitt R, et al.: Unrelated bone marrow donor transplant for children with leukemia or myelodysplasia. Blood 85:2354-2363, 1995